Skip to main content
Clinical Trials/NCT06452238
NCT06452238
Completed
Not Applicable

External Oblique Intercostal Plane Block Versus Ultrasound Guided Transversus Abdominis Plane Block for Postoperative Analgesia in Adult Patients Undergoing Open Nephrectomy

Tanta University1 site in 1 country40 target enrollmentJune 12, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
External Oblique Intercostal Plane Block
Sponsor
Tanta University
Enrollment
40
Locations
1
Primary Endpoint
Total pethidine consumption in the 1st 24hr
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

The aim of this study is to compare external oblique intercostal plane (EOIP) block and ultrasound guided transversus abdominis plane (TAP) Block for postoperative analgesia in adult patients undergoing open nephrectomy.

Detailed Description

Patients undergoing nephrectomy have a high incidence of postoperative pain despite the use of modern laparoscopic surgical techniques. In the postoperative period, these patients are often treated with patient-controlled opioids, epidural analgesia, or both. Ultrasound-guided transversus abdominis plane (TAP) block is a relatively new technique to infiltrate regional anesthesia in which local routine anesthetics are injected between the internal oblique and transverse abdominal muscles. Studies have confirmed that ultrasound-guided (USG) transversus abdominis plane (TAP) block is an effective method of analgesia for upper abdominal surgeries, lower abdominal surgeries, and kidney transplantation, with minimal side effects. External oblique intercostal plane block (EOIPB) has been reported by Elsharkawy et al. in 2021 as a significant modification of fascial plane blocks in that it may engage the upper lateral abdominal walls consistently. In comparison to quadratus lumborum block (QLB) and erector spinae plane block (ESPB) , The advantage of EOIPB is that it may be performed with the patient supine. Furthermore, in comparison to serratus intercostal plane block (SIPB), it generates more extensive analgesic effects throughout the whole midline of the abdomen .

Registry
clinicaltrials.gov
Start Date
June 12, 2024
End Date
October 22, 2025
Last Updated
5 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mohammed Said ElSharkawy

Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Tanta University

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years.
  • Both sexes.
  • American Society of Anesthesiology (ASA) physical status I-II.
  • Scheduled for open nephrectomy.

Exclusion Criteria

  • Bleeding disorders.
  • Skin lesions or infection at the site of proposed needle insertion.
  • Allergy to local anesthetics.
  • Neurological disorders.
  • Drug abuse.
  • BMI \> 30 kg/m
  • Pregnancy.
  • Diabetic neuropathy.
  • Severe cardiovascular problems.

Outcomes

Primary Outcomes

Total pethidine consumption in the 1st 24hr

Time Frame: 24 hours postoperatively

A standardized analgesic regimen will be prescribed in the postoperative period. All patients will receive paracetamol 1 gm every 6 h as routine analgesia. Rescue analgesia of pethidine will be given as 2 mg bolus if the Numerical Rating Scale (NRS) \> 3 to be repeated after 30 min if pain persists until the Numerical Rating Scale (NRS) \< 4. NRS will be assessed at 0, 4, 8, 12, 18 and 24h postoperatively.

Secondary Outcomes

  • Mean arterial pressure(Every 15 minutes till the end of surgery)
  • Intraoperative fentanyl consumption(Intraoperatively)
  • Heart rate(Every 15 minutes till the end of surgery)
  • Time to the 1st rescue analgesia.(24 hours postoperatively)
  • Degree of pain(24 hours postoperatively)

Study Sites (1)

Loading locations...

Similar Trials